7-Hydroxyisoquinoline

1. Product Specifications & Comparative Analysis

Key Differentiators

• Superior thermal stability (3.6% lower decomposition rate at 250°C vs analogs)
• Enhanced solubility in polar solvents (12% higher in ethanol/water mixtures)

2. Detailed Applications

Pharmaceutical Intermediates

Primary application in synthesis of:

• Antineoplastic agents (Phase II clinical trial components)
• Neurological drug precursors (Dopamine analogs)

Organic Synthesis

• Ligand in transition metal catalysis (Cu(II)/Fe(III) complexes)
• Building block for heterocyclic compound development

Material Science

• UV-stabilizing additive in polymer matrices
• Corrosion inhibitor component (pH 3-11 stability)

3. Operational Guidelines

Storage Protocol

• Maintain inert atmosphere (N₂ >99.995%)
• Temperature: 2-8°C for long-term storage

Handling Requirements

• PPE: Nitrile gloves (0.11mm minimum), splash goggles
• Ventilation: ≥4 ACH laboratory-grade fume hood

4. Industry Use Cases

Pharmaceutical Manufacturing

Used in continuous flow synthesis of:

• PARP inhibitors (Batch yield improvement: 18-22%)
• Antimalarial drug intermediates (Purity >99.8%)

Academic Research

• Key reagent in asymmetric catalysis studies (J. Org. Chem. 2024)
• Substrate for enzyme inhibition assays (IC₅₀ 2.3μM)

5. Client Success Stories

Case Study 1: Top 10 Pharma Company

• Application: Scale-up of kinase inhibitor production
• Results: 30% reduction in side products vs previous intermediates
• Throughput: 850kg/month GMP-grade material

Case Study 2: University Research Consortium

• Application: Development of novel metal-organic frameworks
• Outcome: 2 patents filed for catalytic systems
• Publication: Nature Chemistry (2024 Impact Factor: 24.8)

6. Contact for Technical Consultation

For bulk orders (>5kg) or custom synthesis requirements:

• Email: info@vivalr.com
• Phone: (86) 15866781826

Technical support available 24/7 with average response time <45 minutes